MTNB - upcoming catalyst - longMatinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.
This is not
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.9928 USD
−24.25 M USD
0.00 USD
4.56 M
About Matinas Biopharma Holdings, Inc.
Sector
Industry
CEO
Jerome D. Jabbour
Website
Headquarters
Bedminster
Founded
2013
FIGI
BBG005WX2XG8
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
MTNB 1W Long Then ShortWave (4) reprieve of (5) down. Breakout play measured move confluent with wave (4) retracement. Terminal point and wave (5) confluent.
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanoc
As requested, here it is my analysis on MTNB!As another request, I’ll analyze MTNB today! This time for @D0981237654!
The stock has low liquidity, so, the intraday chart is hard to read. But we have some good signs in the daily chart. We have an inverted head and shoulders + an advanced breakout on the RSI.
In the weekly chart we are above
MTNB - Bullish Weekly - Trade the Zones - Play the TicksI actually trade this for 15-20% gains on deep supply zones. Last time I got in was .51 so not bad if you understand where to buy in. I like the swings in this stock and has some volume. Bullish weekly at least to start off next week. Might fail right away with the resistance and the highs. Just nee
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of MTNB is 0.6700 USD — it has increased by 12.61% in the past 24 hours. Watch Matinas Biopharma Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Matinas Biopharma Holdings, Inc. stocks are traded under the ticker MTNB.
MTNB stock has risen by 19.11% compared to the previous week, the month change is a 16.52% rise, over the last year Matinas Biopharma Holdings, Inc. has showed a −92.56% decrease.
MTNB reached its all-time high on Mar 2, 2017 with the price of 199.5000 USD, and its all-time low was 0.4748 USD and was reached on Apr 8, 2025. View more price dynamics on MTNB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MTNB stock is 14.43% volatile and has beta coefficient of 1.40. Track Matinas Biopharma Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Matinas Biopharma Holdings, Inc. there?
Today Matinas Biopharma Holdings, Inc. has the market capitalization of 3.03 M, it has increased by 11.11% over the last week.
Yes, you can track Matinas Biopharma Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Matinas Biopharma Holdings, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
MTNB net income for the last quarter is −8.43 M USD, while the quarter before that showed −4.28 M USD of net income which accounts for −97.26% change. Track more Matinas Biopharma Holdings, Inc. financial stats to get the full picture.
No, MTNB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 26, 2025, the company has 3 employees. See our rating of the largest employees — is Matinas Biopharma Holdings, Inc. on this list?
Like other stocks, MTNB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Matinas Biopharma Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Matinas Biopharma Holdings, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Matinas Biopharma Holdings, Inc. stock shows the sell signal. See more of Matinas Biopharma Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.